Micro-RNA-155 inhibits IFN-γ signaling in CD4+ T cells

Arnob Banerjee(Johnson & Johnson (United States)), Scott M. Hammond(University of North Carolina at Chapel Hill), Felix Schambach(The Wistar Institute), Steven L. Reiner(Columbia University Irving Medical Center), Caitlin S. DeJong(The Wistar Institute)

UNC Libraries

November 2, 2020

10.17615/b596-jh40

Cited by 0

Related Papers

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

|The Lancet|2021|1.7k

Teclistamab in Relapsed or Refractory Multiple Myeloma

|New England Journal of Medicine|2022|1.2k

Asymmetric T Lymphocyte Division in the Initiation of Adaptive Immune Responses

|Science|2007|852

Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing

|RNA|2008|678

Ciltacabtagene Autoleucel, an Anti–B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up

|Journal of Clinical Oncology|2022|647